Prognostic significance of progesterone receptor in hormonal receptor-positive breast cancer: Association with endocrine resistance

被引：0
|
作者：
Bae, S. Y. [1 ]
Lee, S. K. [1 ]
Lee, J. H. [1 ]
Lee, H. [1 ]
Kim, M. [1 ]
Kim, J. [1 ]
Kil, W. H. [1 ]
Lee, J. E. [1 ]
Nam, S. J. [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P5-09-17
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-09-17
引用
收藏
页数：2
相关论文
共 50 条
  • [31] miRNA signatures of prognostic significance in single hormone receptor-positive breast cancer.
    Senkus-Konefka, Elzbieta
    Popeda, Marta
    Kunc, Michal
    Bienkowski, Michal
    Braun, Marcin
    Lacko, Aleksandra
    Radecka, Barbara
    Pikiel, Joanna
    Litwiniuk, Maria
    Pogoda, Katarzyna
    Izycka-Swieszewska, Ewa
    Zaczek, Anna Joanna
    Biernat, Wojciech
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [32] Fibroblast growth factor receptor signaling in estrogen receptor-positive breast cancer: mechanisms and role in endocrine resistance
    Marin, Arnaldo
    Morales, Fernanda
    Walbaum, Benjamin
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [33] The prognostic significance of discordant receptor results and the progesterone receptor in metastatic breast cancer
    Stuart-Harris, R.
    Shadbolt, B.
    Ross, H. A. Chaudri
    EJC SUPPLEMENTS, 2008, 6 (07): : 171 - 171
  • [34] The clinical significance of the estrogen receptor beta expression for endocrine therapy in patients with estrogen receptor alpha-negative and progesterone receptor-positive breast carcinoma
    Park, M. H.
    Ro, H. W.
    Cho, J. S.
    Yoon, J. H.
    Jegal, Y. J.
    Lee, J. S.
    Choi, M. S.
    Youn, H. J.
    Jung, S. H.
    EJC SUPPLEMENTS, 2010, 8 (03): : 168 - 168
  • [35] Cofilin Expression in Breast Carcinoma with Hormone Receptor-Positive: Prognostic Significance
    Aranda, F. I.
    Segui, J.
    Sanchez-Tejada, L.
    Niveiro, M.
    Laforga, J.
    Alenda, C.
    Planelles, M.
    Peiro, G.
    MODERN PATHOLOGY, 2009, 22 : 27A - 27A
  • [36] Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer
    Van Asten, Kathleen
    Slembrouck, Laurence
    Olbrecht, Siel
    Jongen, Lynn
    Brouckaert, Olivier
    Wildiers, Hans
    Floris, Giuseppe
    Van Limbergen, Erik
    Weltens, Caroline
    Smeets, Ann
    Paridaens, Robert
    Giobbie-Hurder, Anita
    Regan, Meredith M.
    Viale, Giuseppe
    Thurlimann, Beat
    Vergote, Ignace
    Christodoulou, Evangelia
    Van Calster, Ben
    Neven, Patrick
    ONCOLOGIST, 2019, 24 (02): : 165 - 171
  • [37] Isolated Loss of Hormonal Receptors in Leptomeningeal Metastasis From Estrogen Receptor- and Progesterone Receptor-Positive Lobular Breast Cancer
    Grewal, Jai
    Zhou, Huadong
    Factor, Rachel
    Kesari, Santosh
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) : E200 - E202
  • [38] Natural history of estrogen receptor-negative, progesterone receptor-positive breast cancer
    Nikoic-Vukosavljevic, D
    Kanjer, K
    Neskovic-Konstantinovic, Z
    Vukotic, D
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03): : 196 - 200
  • [39] Cofilin Expression in Breast Carcinoma with Hormone Receptor-Positive: Prognostic Significance
    Aranda, F. I.
    Segui, J.
    Sanchez-Tejada, L.
    Niveiro, M.
    Laforga, J.
    Alenda, C.
    Planelles, M.
    Peiro, G.
    LABORATORY INVESTIGATION, 2009, 89 : 27A - 27A
  • [40] Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients
    Yu, Ke-Da
    Liu, Guang-Yu
    Di, Gen-Hong
    Wu, Jiong
    Lu, Jin-Song
    Shen, Kun-Wei
    Shen, Zhen-Zhou
    Shao, Zhi-Ming
    BREAST, 2007, 16 (03): : 307 - 315
12345